Curbing our enthusiasm for fecal transplantation in ulcerative colitis
- PMID: 24091506
- DOI: 10.1038/ajg.2013.279
Curbing our enthusiasm for fecal transplantation in ulcerative colitis
Abstract
Given the known dysbiosis of gut microflora in inflammatory bowel disease, there has been great enthusiasm about the potential for fecal microbiota transplantation (FMT) as a treatment. This editorial accompanies a prospective series of five patients with ulcerative colitis who underwent FMT, but did not achieve remission. I discuss the important observations from this study and point out that the lack of clinical efficacy and observed side effects warrant caution in the ongoing pursuit of this treatment option.
Comment on
-
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.Am J Gastroenterol. 2013 Oct;108(10):1620-30. doi: 10.1038/ajg.2013.257. Epub 2013 Sep 24. Am J Gastroenterol. 2013. PMID: 24060759
Similar articles
-
Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis.Inflamm Bowel Dis. 2013 Sep;19(10):2155-65. doi: 10.1097/MIB.0b013e31829ea325. Inflamm Bowel Dis. 2013. PMID: 23899544
-
Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation.Am J Gastroenterol. 2013 Oct;108(10):1620-30. doi: 10.1038/ajg.2013.257. Epub 2013 Sep 24. Am J Gastroenterol. 2013. PMID: 24060759
-
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.Gastroenterology. 2015 Jul;149(1):110-118.e4. doi: 10.1053/j.gastro.2015.03.045. Epub 2015 Mar 30. Gastroenterology. 2015. PMID: 25836986 Clinical Trial.
-
Fecal microbiota transplantation: techniques, applications, and issues.Gastroenterol Clin North Am. 2012 Dec;41(4):781-803. doi: 10.1016/j.gtc.2012.08.008. Gastroenterol Clin North Am. 2012. PMID: 23101687 Review.
-
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.Drugs Today (Barc). 2018 Feb;54(2):123-136. doi: 10.1358/dot.2018.54.2.2760765. Drugs Today (Barc). 2018. PMID: 29637938 Review.
Cited by
-
Update of Probiotics in Human World: A Nonstop Source of Benefactions till the End of Time.Microorganisms. 2020 Nov 30;8(12):1907. doi: 10.3390/microorganisms8121907. Microorganisms. 2020. PMID: 33266303 Free PMC article. Review.
-
A Phase 1b Safety Study of SER-287, a Spore-Based Microbiome Therapeutic, for Active Mild to Moderate Ulcerative Colitis.Gastroenterology. 2021 Jan;160(1):115-127.e30. doi: 10.1053/j.gastro.2020.07.048. Epub 2020 Aug 4. Gastroenterology. 2021. PMID: 32763240 Free PMC article. Clinical Trial.
-
Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.Gastroenterol Clin North Am. 2017 Dec;46(4):689-729. doi: 10.1016/j.gtc.2017.08.002. Gastroenterol Clin North Am. 2017. PMID: 29173517 Free PMC article. Review.
-
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.Clin Microbiol Rev. 2017 Jan;30(1):191-231. doi: 10.1128/CMR.00049-16. Clin Microbiol Rev. 2017. PMID: 27856521 Free PMC article. Review.
-
Fecal transplantation - the new, inexpensive, safe, and rapidly effective approach in the treatment of gastrointestinal tract diseases.J Med Life. 2016 Apr-Jun;9(2):160-2. J Med Life. 2016. PMID: 27453747 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical